共 50 条
- [4] A new standard for EGFR-mutant NSCLC? [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (10) : 593 - 593
- [5] A new standard for EGFR-mutant NSCLC? [J]. Nature Reviews Clinical Oncology, 2019, 16 : 593 - 593
- [6] Erlotinib as adjuvant therapy in EGFR-mutant NSCLC [J]. LANCET RESPIRATORY MEDICINE, 2018, 6 (11): : 808 - 810
- [7] EGFR-mutant NSCLC: emerging novel drugs [J]. CURRENT OPINION IN ONCOLOGY, 2021, 33 (01) : 87 - 94